Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
from NDTV News - Latest https://ift.tt/3bIUCMT
via
